← Back to Search

Behavioural Intervention

Electrodermal Activity Signals for Osteoarthritis

N/A

Waitlist Available

Led By Peter L Schilling, MD, MS

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Kellgren-Lawrence Grade >= 3

Be older than 18 years old

Must not have

Inflammatory arthropathy (e.g., rheumatoid arthritis), BMI >=35

Women who are currently pregnant

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 40 minutes of test time, occurring all in one day.

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if a smartwatch can accurately measure pain levels in people with osteoarthritis by tracking their skin's electrical activity. If successful, this method could be used in larger studies

Who is the study for?

This trial is for individuals with osteoarthritis. The study aims to include participants who can provide reliable data through a smartwatch-based sensor.

What is being tested?

The trial is testing the use of a smartwatch-based electrodermal activity (EDA) sensor to measure pain levels in people with osteoarthritis, as part of a pilot study before larger-scale research.

What are the potential side effects?

Since this study involves non-invasive monitoring using a smartwatch, there are no direct side effects associated with the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My knee arthritis is severe.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a condition like rheumatoid arthritis and my BMI is 35 or higher.

Select...

I am currently pregnant.

Select...

I have a long-term heart condition, such as high blood pressure or irregular heartbeat.

Select...

I do not have skin issues, vertigo, POTS, neuropathy, seizures, MRSA, circulation problems, implants, eczema on hands, diabetes, or epilepsy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 40 minutes of test time, occurring all in one day.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~40 minutes of test time, occurring all in one day.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 40 minutes of test time, occurring all in one day. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

:Difference in pain measurements as reported by the participant via a visual analogue scale versus smartwatch reported electrodermal activity sensors

Accuracy of predicting patient pain from electrodermal activity signal (EDA) during standardized Osteoarthritis Research Society International (OARSI) function tests

Electrodermal activity (EDA) signals during standardized Osteoarthritis Research Society International (OARSI) 30-second chair test

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Electrodermal Activity Measurement SubjectsExperimental Treatment1 Intervention

Participants will have their baseline electrodermal activity (EDA) response to pain measured as well as their EDA response measured while participating in a set of standardized functional tests.

0 / 5Eligibility criteria met